Cite
HARVARD Citation
Shu, C. et al. (2020). Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial. Lancet oncology. 21 (6), pp. 786-795. [Online].